The drug discovery ecosystem is changing rapidly. The rise of robotics and AI enables the emergence of a new model of data-driven drug discovery. Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process.
The webinar will provide an overview on large-scale data and metadata capture enabled by end-to-end automation, going beyond what is currently possible in traditional wet lab operations, and will present case studies showing the impact on biotech and pharma operations, providing actionable insights for biopharma leaders.
Dr. Martin-Immanuel Bittner completed his medical degree in Germany and his DPhil in Oncology as a Rhodes Scholar at the University of Oxford. He worked in both clinical trials and drug discovery, is a member of AACR, EACR and ESTRO, actively involved in the Open Science movement, and in 2018 was elected a member of the Young Academy of the German National Academy of Sciences in recognition of his research achievements.